Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

AMS Stock Surges 16%: Is Advanced Medical Solutions a Breakout Story or Overbought Risk?

Few corners of the London market attract attention faster than a stock flashing an extreme momentum reading, and Advanced Medical Solutions Group plc (LSE:AMS) has done exactly that, appearing among the most overbought UK shares screened by RSI. With a 14-day RSI of 74.53 …

Ankur Sharma | 26 June 2026

FDBK Shares Flash Oversold Signal: Is Feedback plc Too Cheap After Market Pressure?

Feedback (FDBK) has been flagged on UK 'most undervalued' and oversold stock screens, largely because its Relative Strength Index (RSI) has fallen toward levels traders associate with oversold conditions after a period of share-price weakness. As a medical imaging and clinical data technology company, …

Divya Sood | 26 June 2026

EDX Shares Fall: Is EDX Medical Now an Oversold Healthcare Watch?

EDX Medical Group (EDX) has been flagged on UK 'most undervalued' and oversold stock screens, largely because its Relative Strength Index (RSI) has fallen toward levels traders associate with oversold conditions after a period of share-price weakness. As a diagnostics and precision-medicine company, its …

Divya Sood | 26 June 2026

CRTX Stock Slides Into Oversold Territory: Is CRISM Therapeutics Near a Turning Point?

CRISM Therapeutics (CRTX) has been flagged on UK 'most undervalued' and oversold stock screens, largely because its Relative Strength Index (RSI) has fallen toward levels traders associate with oversold conditions after a period of share-price weakness. As a clinical-stage therapeutics company, its valuation is …

Divya Sood | 26 June 2026

CNSL Shares Hit Oversold Zone: Is Cambridge Nutritional Sciences a Deep-Value Healthcare Play?

Cambridge Nutritional Sciences (CNSL) has been flagged on UK 'most undervalued' and oversold stock screens, largely because its Relative Strength Index (RSI) has fallen toward levels traders associate with oversold conditions after a period of share-price weakness. As a diagnostics and nutritional health testing …

Divya Sood | 26 June 2026

AREC Shares Look Undervalued: Is Arecor Therapeutics Being Mispriced by the Market?

Arecor Therapeutics (AREC) has been flagged on UK 'most undervalued' and oversold stock screens, largely because its Relative Strength Index (RSI) has fallen toward levels traders associate with oversold conditions after a period of share-price weakness. As a biopharmaceutical formulation technology company, its valuation …

Divya Sood | 26 June 2026

Why Is Scancell Holdings Trending on Google Finance Today? Latest Clinical Pipeline Outlook

Scancell Holdings plc attracted investor attention after its shares declined approximately 7.14% during trading on 25 June 2026. The move placed the biotechnology company among the notable healthcare fallers on London's AIM market and prompted investors to evaluate whether the decline reflected company-specific developments …

Ankur Sharma | 26 June 2026

Provexis Shares Slide 9.09% Despite Long-Term Healthcare Growth Opportunities

Provexis PLC came under selling pressure on 25 June 2026, with its shares declining approximately 9.09% during the trading session. The move placed the company among the day's notable AIM fallers and generated increased interest from retail investors seeking to understand the reasons behind …

Ankur Sharma | 26 June 2026

AIM:GENI Slides as Investors Reassess Precision Medicine and Genomics Stocks

• AIM:GENI – GENinCode Plc declined approximately 9.09% on 25 June 2026, making it one of the notable healthcare fallers on London's AIM market.

Ankur Sharma | 26 June 2026

Abingdon Health Shares Drop Despite Growing Point-of-Care Testing Opportunities

• AIM:ABDX – Abingdon Health Plc declined approximately 8.11% on 25 June 2026, making it one of the notable healthcare sector fallers on the AIM market.

Ankur Sharma | 26 June 2026
Support

Hi! How can we help you today?

Loading…